Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Total 13F shares
-
250,410,928
-
Share change
-
+2,988,452
-
Total reported value
-
$10,263,954,175
-
Put/Call ratio
-
40%
-
Price per share
-
$40.99
-
Number of holders
-
229
-
Value change
-
+$118,347,007
-
Number of buys
-
142
-
Number of sells
-
90
Institutional Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q2 2021
As of 30 Jun 2021,
Royalty Pharma plc - Common Stock (RPRX) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
250,410,928 shares.
The largest 10 holders included
MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors, BlackRock Inc., Vantage Consulting Group Inc, JPMORGAN CHASE & CO, HARVARD MANAGEMENT CO INC, and SIGULER GUFF ADVISERS, LLC.
This page lists
229
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.